I've mentioned these guys, in the context of MDS, around here someplace. MDS is a very interesting company.
Monday July 10, 12:07 pm Eastern Time
Company Press Release
SOURCE: Protana A/S
Protana Appoints Ronald C. Hendrickson, Ph. D., As
Head of Business Development
ODENSE, Denmark, July 10 /PRNewswire/ -- Protana A/S, a privately held, proteomics
technology company, today announced the appointment of Ronald C. Hendrickson, Ph. D. as head of business development.
Hendrickson joins Protana A/S from Corixa Corporation, in Seattle, Washington, where he established and led the proteomics
efforts to identify protein antigens and diagnostic markers.
Dr. Hendrickson's accomplishments include being the first to identify an MHC Class I human tumor antigen that results from
post-translational modification, a phenomena that is not predictable from genomic data but critical for understanding disease
and developing certain therapeutics. In addition, he has pushed the envelope on mass spectrometry instrument performance to
sequence unknown proteins a hundred times more sensitive than previous methods. Prior to joining Protana, Dr. Hendrickson
lead the proteomics effort at Corixa Corporation to identify tumor antigens and diagnostic markers for Breast Cancer and
Tuberculosis.
Protana is the world's leading proteomics company founded in 1997 and headquartered in Odense, Denmark. It is a privately
held company affiliated with MDS, a Canadian Health Science company. For more information about Protana A/S, please visit
our Website at protana.com . (photograph available).
SOURCE: Protana A/S |
